Evidence map›Paper›PMID 35053333›Full record

ArticleCells2022

The Multiple Faces of the GH/IGF Axis.

Vera Chesnokova

Abstract readEditorial
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Insulin- Like Growth Factor-1 as Brain-Body Connector.Advances in experimental medicine and biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Vera ChesnokovaPituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Funding

Mechanisms for GH action on epithelial cellsR01DK113998 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI SHLOMO MELMED · 2018 to 2026
$3.0M
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovitR21DK103198 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI MELMED, SHLOMO · 2014 to 2015
$445k
NIDDK NIH HHS R01 DK113998NIH HHS DK103198
6 · The paper itself

Abstract

Over the past two decades, interest in the role of the somatotroph growth hormone/insulin-like growth factor (GH/IGF1) axis in multiple aspects of physiology and pathology has grown exponentially [...].

Indexed as

Signal TransductionAgingAnimalsGenomicsGrowth HormoneHumansSomatomedinsGrowth HormoneSomatomedins

Identifiers

PMID35053333
PMCPMC8773948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.